Company Overview
About Unity Biotechnology
Unity Biotechnology is the most clinically advanced senolytic drug company, with its UBX1325 program delivering long-lasting vision improvements in diabetic macular edema (DME) from a single intravitreal senolytic injection. The 48-week Phase 2 BEHOLD trial data published in NEJM Evidence (one of the highest-impact medical journals) confirmed durable efficacy — maintained vision improvement with a single injection over nearly a year — validating the senolytic hypothesis in human ocular disease.
Business Model & Competitive Advantage
UBX1325 is a BCL-xL inhibitor that selectively induces apoptosis in senescent microvascular endothelial cells in the diabetic retina, which are thought to drive DME through SASP-mediated vascular permeability and inflammatory signaling. A single injection clears these senescent cells and the inflammatory environment they create, allowing the remaining healthy cells to restore vascular function. The NEJM Evidence publication provides the academic credibility needed to inform Phase 3 trial design.
Competitive Landscape 2025–2026
Unity is a bellwether for the senolytic field: its eye programs have provided the first controlled human evidence that removing senescent cells has durable therapeutic benefit, establishing the biological basis that the broader senolytic category depends on. Phase 3 design decisions being made in 2026 will determine whether UBX1325 advances toward regulatory approval and market launch — which would be the first FDA-approved senolytic drug in history.
Open Positions
Reddit Discussions
Key Differentiators
Emerging Innovator
Unity Biotechnology is an emerging player bringing innovative solutions to the BioTech market.
Frequently Asked Questions
Not So Random Others
a2z Radiology AI
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disea
Adept AI
Adept AI was founded in 2022 by a team of former OpenAI, DeepMind, and Google Brain researchers to build AI that can take actions on computers — navigating software interfaces, filling forms, and exec
Duckie
Duckie is a San Francisco-based AI customer support platform — backed by Y Combinator (W24) with $500,000 in funding from Y Combinator, Andreessen Horowitz, Greylock, KungHo Fund, Netflix, and 5 addit
Plenty
Plenty is a San Francisco-based indoor vertical farming company that uses AI, machine learning, and robotics to grow leafy greens and other produce in controlled indoor environments. The company has r
Oura
Oura is the maker of the Oura Ring, a premium smart ring that tracks sleep, recovery, readiness, and health metrics through continuous biometric sensing. The company raised $900 million in Series E fi
Nira Energy
Nira Energy is a Denver-based renewable energy software company providing grid capacity mapping and interconnection analysis tools that help solar, battery storage, and data center developers identify
Compare Unity Biotechnology with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Unity Biotechnology? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Unity Biotechnology Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Unity Biotechnology vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →